Beckman Coulter launched a urinalysis analyzer at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo.
The DxU Iris Workcell is a fully automated system that streamlines urinalysis workflow and reduces manual reviews to 4%, the company said.
A routine urinalysis is one the most frequently ordered tests, representing up to 30% of all samples received in the lab. Given the volume, “the most important thing is to minimize disruptions in the workflow,” explained Matthew Rhyner, PhD, MBA, Vice President and General Manager of Urinalysis at Beckman Coulter. However, that is typically not the case in urinalysis because lab technicians often perform manual inspections of samples, which causes the process to take up to six times longer than would be the case with an automated system.
To solve that problem, the DxU Iris Workcell allows urinalysis operators to automatically classify sediment particles, minimizing the need for manual inspections.
The DxU Iris Workcell pairs the DxU 850m Iris or DxU 840m Iris urine microscopy analyzer with the Arkray AUTION MAX 4030 urine chemistry analyzer to create a scalable, fully automated urinalysis solution. The workcell was developed with proprietary Digital Flow Morphology technology with Auto-Particle Recognition (APR) Software, which enables laboratories to deliver standardized results using artificial intelligence (AI).
The analyzer integrates with Beckman Coulter’s informatics software solutions: PROService remote service tool, DxONE Command Central remote monitoring, and REMISOL Advance middleware.
“We have taken what people like about the iQ (Series Urinalysis Workcell) and added a lot of enhancements,” Rhyner said.
